An 83-year-old man presents to the gastroenterologist to follow-up on results from a biopsy of a pancreatic head mass, which the clinician was concerned could be pancreatic cancer. After welcoming the patient and his wife to the clinic, the physician begins to discuss the testing and leads into delivering the results, which showed metastatic pancreatic adenocarcinoma. Before she is able to disclose these findings, the patient stops her and exclaims, "Whatever it is, I don't want to know. Please just make me comfortable in my last months alive. I have made up my mind about this." Which of the following is the most appropriate response on the part of the physician?

"If that is your definite wish, then I must honor it"

"The cancer has spread to your liver"

"As a physician, I am obligated to disclose these results to you"

"If you don't know what condition you have, I will be unable to be your physician going forward"

"Please, sir, I strongly urge you to reconsider your decision"

A 72-year-old man is admitted to the hospital with productive cough and fever. A chest radiograph is obtained and shows lobar consolidation. The patient is diagnosed with pneumonia. He has a history of penicillin allergy. The attending physician orders IV levofloxacin as empiric therapy. On morning rounds the next day, the team discovers that the patient was administered ceftriaxone instead of levofloxacin. The patient has already received a full dose of ceftriaxone and had no signs of allergic reaction, and his pneumonia appears to be improving clinically. What is the most appropriate next step?

Continue with ceftriaxone and add azithromycin as inpatient empiric pneumonia therapy

Administer diphenhydramine as prophylaxis against allergic reaction

Continue with ceftriaxone as empiric therapy

Switch the patient to oral azithromycin in preparation for discharge and home therapy

Switch the patient back to levofloxacin and discuss the error with the patient

A 52-year-old man with stage IV melanoma comes to the physician with his wife for a routine follow-up examination. He was recently diagnosed with new bone and brain metastases despite receiving aggressive chemotherapy but has not disclosed this to his wife. He has given verbal consent to discuss his prognosis with his wife and asks the doctor to inform her of his condition because he does not wish to do so himself. She is tearful and has many questions about his condition. Which of the following would be the most appropriate statement by the physician to begin the interview with the patient's wife?

What is your understanding of your husband's current condition?

Have you discussed a living will or goals of care together?

We should talk about how we can manage his symptoms with additional chemotherapy.

Why do you think your husband has not discussed his medical condition with you?

Your husband has end-stage cancer, and his prognosis is poor.

A 65-year-old man is admitted to the hospital because of a 1-month history of fatigue, intermittent fever, and weakness. Results from a peripheral blood smear taken during his evaluation are indicative of possible acute myeloid leukemia. Bone marrow aspiration and subsequent cytogenetic studies confirm the diagnosis. The physician sets aside an appointed time-slot and arranges a meeting in a quiet office to inform him about the diagnosis and discuss his options. He has been encouraged to bring someone along to the appointment if he wanted. He comes to your office at the appointed time with his daughter. He appears relaxed, with a full range of affect. Which of the following is the most appropriate opening statement in this situation?

What is your understanding of the reasons we did bone marrow aspiration and cytogenetic studies?

Your lab reports show that you have an acute myeloid leukemia

You must be curious and maybe even anxious about the results of your tests.

I may need to refer you to a blood cancer specialist because of your diagnosis. You may need chemotherapy or radiotherapy, which we are not equipped for.

Would you like to know all the details of your diagnosis, or would you prefer I just explain to you what our options are?

A 64-year-old woman presents to the physician’s office to find out the results of her recent abdominal CT. She had been complaining of fatigue, weight loss, and jaundice for 6 months prior to seeing the physician. The patient has a significant medical history of hypothyroidism, generalized anxiety disorder, and hyperlipidemia. She takes levothyroxine, sertraline, and atorvastatin. The vital signs are stable today. On physical examination, her skin shows slight jaundice, but no scleral icterus is present. The palpation of the abdomen reveals no tenderness, guarding, or masses. The CT results shows a 3 x 3 cm mass located at the head of the pancreas. Which of the following choices is most appropriate for delivering bad news to the patient?

Set aside an appropriate amount of time in your schedule, and ensure you will not have any interruptions as you explain the bad news to the patient

Refer the patient to an oncologist without informing the patient of their cancer

Ask that a spouse or close relative come to the appointment, explain to them the bad news, and see if they will tell the patient since they have a closer relationship

Call the patient over the phone to break the bad news, and tell them they can make an office visit if they prefer

Train one of the nursing staff employees on this matter, and delegate this duty as one of their job responsibilities

A 47-year-old woman comes to the physician for a mass in her left breast she noticed 2 days ago during breast self-examination. She has hypothyroidism treated with levothyroxine. There is no family history of breast cancer. Examination shows large, moderately ptotic breasts. The mass in her left breast is small (approximately 1 cm x 0.5 cm), firm, mobile, and painless. It is located 4 cm from her nipple-areolar complex at the 7 o'clock position. There are no changes in the skin or nipple, and there is no palpable axillary adenopathy. No masses are palpable in her right breast. A urine pregnancy test is negative. Mammogram showed a soft tissue mass with poorly defined margins. Core needle biopsy confirms a low-grade infiltrating ductal carcinoma. The pathological specimen is positive for estrogen receptors and negative for progesterone and human epidermal growth factor receptor 2 (HER2) receptors. Staging shows no distant metastatic disease. Which of the following is the most appropriate next step in management?

Lumpectomy with sentinel lymph node biopsy, followed by radiation and hormone therapy

Lumpectomy with sentinel lymph node biopsy followed by hormone therapy

Nipple-sparing mastectomy with axillary lymph node dissection followed by hormone therapy

Nipple-sparing mastectomy with axillary lymph node dissection, followed by radiation and hormone therapy

Radical mastectomy followed by hormone therapy

A 38-year-old woman with BRCA1 mutation and strong family history of breast and ovarian cancer (mother and sister both affected) undergoes bilateral prophylactic mastectomy. Final pathology unexpectedly reveals a 0.6 cm focus of ductal carcinoma in situ (DCIS) in the right breast, high-grade, with clear margins. She has not yet undergone risk-reducing salpingo-oophorectomy. She desires breast reconstruction. Evaluate the comprehensive management strategy.

No additional breast surgery needed; proceed with immediate reconstruction and discuss oophorectomy timing

Radiation therapy to mastectomy site; delayed reconstruction; oophorectomy after radiation

Observation of surgical site; proceed with reconstruction; defer oophorectomy until age 40

Re-excision to wider margins; delayed reconstruction after confirming no invasion; immediate oophorectomy

Genetic counseling; additional oncologic surgery consultation; defer all additional procedures

Multidisciplinary cancer care for USMLE Step 2 CK: High-Yield Surgery Lessons

🤝 The Cancer Dream Team

Multidisciplinary Team (MDT) / Tumor Board: A collaborative group of specialists who jointly manage cancer patients, representing the modern standard of care.
Primary Goal: To develop a comprehensive, individualized treatment plan by reaching a consensus on diagnosis, staging, and the optimal sequence of therapies.

Multidisciplinary Tumor Board Discussing Patient Scans

Core Members (📌 SMRRP):
- Surgical Oncologist: Manages surgical resection.
- Medical Oncologist: Administers systemic therapy (chemo, immunotherapy).
- Radiation Oncologist: Delivers local radiation therapy.
- Radiologist: Interprets imaging for staging.
- Pathologist: Provides tissue diagnosis & molecular profiling.
Key Ancillary Support: Palliative care, genetics, social work, nutrition, oncology nursing.

⭐ High-Yield: The MDT approach is strongly associated with improved survival, better adherence to evidence-based guidelines, and increased patient enrollment in clinical trials.

🤝 Management - The Tumor Board Huddle

A regularly scheduled meeting where a multidisciplinary team (MDT) discusses individual cancer cases to formulate a consensus treatment plan. It is the cornerstone of modern, patient-centered oncologic care.

Key Objectives:
- Establish accurate diagnosis & staging.
- Develop evidence-based, personalized treatment plans.
- Improve inter-specialty communication & coordination.
- Increase enrollment in clinical trials.
- Ensure adherence to NCCN/ASCO guidelines.
Core Participants:
- Surgical Oncologist
- Medical Oncologist
- Radiation Oncologist
- Radiologist
- Pathologist
- Nurse Navigator / Coordinator
- Palliative Care, Genetics, Social Work (as needed)

⭐ Multidisciplinary tumor board review can alter the diagnostic, staging, or treatment plan in 10-40% of cancer cases, significantly improving adherence to clinical guidelines and patient outcomes.

Tumor Board Workflow:

💡 The surgeon's input is crucial for determining resectability and the optimal sequence of surgery with neoadjuvant or adjuvant therapies.

🚧 Complications - Communication Breakdowns

Root Causes of Failure:
- Lack of standardized handoffs (e.g., SBAR, I-PASS).
- Information silos from non-integrated Electronic Health Records (EHRs).
- Hierarchical culture discouraging junior members from speaking up.
- Time constraints leading to rushed or incomplete exchanges.
- Diffusion of responsibility ("bystander effect" in a clinical team).
Clinical & System Consequences:
- ⚠️ Medical Errors: Medication mistakes, treatment delays, diagnostic inaccuracies.
- Conflicting information given to patients, causing confusion and anxiety.
- Fragmented care plans with poor execution and follow-up.
- ↓ Patient satisfaction and ↑ provider burnout.

⭐ The Joint Commission estimates that communication failures are a root cause in over 70% of sentinel events (e.g., wrong-site surgery, unexpected death).

⚡ Biggest Takeaways

Multidisciplinary Teams (MDTs) or Tumor Boards are the standard of care for most cancers.

Core members: surgeons, medical/radiation oncologists, pathologists, radiologists.

Goal: Create a comprehensive, individualized treatment plan.

Improves patient outcomes, adherence to guidelines, and clinical trial enrollment.

Key decisions: accurate staging, assessing resectability, and sequencing therapies (neoadjuvant vs. adjuvant).

Promotes shared decision-making with the patient, improving care coordination.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play